Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Molecular Diagnosis & Therapy|July 4, 2019
NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript AnalysisPablo Coto-Segura, Leire González-Lara, Ana Batalla, et al.Dermatology Practical & Conceptual|December 8, 2021
Surgery for Cutaneous Squamous Cell Carcinoma and its Limits in Advanced DiseaseDavid Moreno-Ramírez, Francisca Silva-Clavería, Almudena Fernández-Orland, et al.DNA and Cell Biology|August 3, 2013
SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish cohortLeire González-Lara, Pablo Coto-Segura, Ana Penedo, et al.Archives of Dermatological Research|December 25, 2014
The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patientsLeire González-Lara, Ana Batalla, Eliecer Coto, et al.Human Immunology|March 6, 2017
NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variantPablo Coto-Segura, Leire Gonzalez-Lara, Juan Gómez, et al.Cytokine|June 29, 2012
Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypesNoemí Eiris, Jorge Santos-Juanes, Pablo Coto-Segura, et al.Pharmacy (Basel, Switzerland)|May 27, 2026
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS)Mar Llamas-Velasco, Mercedes Hospital, Anna López-Ferrer, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2023
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis GroupSonsoles Berenguer-Ruiz, Mario Aparicio-Domínguez, Pedro Herranz-Pinto, et al.Pageof 1